
|Videos|October 31, 2015
How the FDA Views Compounding
Ronna B. Hauser, PharmD, vice president of pharmacy affairs for the National Community Pharmacists Association (NCPA), talks about the current position of the FDA regarding compounding.
Advertisement
Ronna B. Hauser, PharmD, vice president of pharmacy affairs for the National Community Pharmacists Association (NCPA), talks about the current position of the FDA regarding compounding.
This video was recorded at the 2015 NCPA Annual Convention.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Milestone Oral Therapy for Adults With Thalassemia Anemia
2
Reimagining Pharmacy: A Call to Action for Pharmacy Professionals
3
FDA Approves Nufymco, Interchangeable Ranibizumab Biosimilar, for Retinal Diseases
4
Lowering Blood Glucose in Prediabetes May Prevent Heart Attacks and Heart Failure
5









































































































































































































